cefovecin

Cefovecin is a third-generation cephalosporin antibiotic used in veterinary medicine. It is administered intravenously or subcutaneously and is approved for use in dogs and cats. Cefovecin is a broad-spectrum antibiotic effective against a range of Gram-positive and Gram-negative bacteria. Its primary mechanism of action involves inhibiting bacterial cell wall synthesis, leading to bacterial death.

The long-acting nature of cefovecin is a significant characteristic. It is formulated for a single administration that can provide therapeutic levels for up to two weeks. This extended duration of action makes it particularly useful for treating conditions where sustained antibiotic coverage is beneficial, or when compliance with oral medication might be challenging. Cefovecin is indicated for the treatment of skin and soft tissue infections, including abscesses and wound infections, as well as urinary tract infections in dogs and cats.

Common side effects associated with cefovecin are generally mild and can include pain or swelling at the injection site, and gastrointestinal upset such as vomiting or diarrhea. Allergic reactions, although rare, can occur. Like other antibiotics, cefovecin can lead to the development of antibiotic resistance if not used appropriately. Prescribing veterinarians consider the specific bacterial pathogens involved, their susceptibility patterns, and the overall health status of the animal when determining the suitability of cefovecin for treatment. Its use is typically guided by diagnostic testing to ensure efficacy and minimize the risk of resistance.